A CLINICAL STUDY ON HARIDRA (CURCUMA LONGA LINN.), DARUHARIDRA (BERBERIS ARISTATA DC.) AND AMALAKI (EMBLICA OFFICINALIS GAERTN.) IN MADHUMEHA (DM TYPE 2)
Sarvesh Kumar Bharati*, Bhuwal Ram, Surya Kumar Singh and Anil Kumar Singh
Ayurveda was practiced and preached for the betterment of human beings. Its primary aim was attainment of
sustainable health while patients were treated by using natural products. The present clinical study was done with
an aim to evaluate the Effect of Haridra (Curcuma longa Linn.) and Daruharidra (Berberis aristata DC.) processed
with Amalaki (Emblica officinalis Gaertn.) swarasa in Madhumeha (DM Type 2). According to Ayurveda,
Madhumeha is defined as the disease in which patient voids urine similar to Madhu (honey) in taste and colour.
Diabetes mellitus is a syndrome, characterized by hyperglycemia resulting from defects in insulin secretion, insulin
resistance or both. In India, the prevalence of Type 2 DM between age group 20-79 years is 91.3 million in year
2011 and expected data in 2030 is 101.2 million according to International Diabetes Federation. Present study
consists of 60 registered cases of Type 2 DM which is divided in 3 groups i.e. Group A, B and C having 20 cases in
each. Out of these, 10 cases did not follow the treatment thus the present study population includes only 50
patients. Group A was treated with trial drug, group B was treated with tablet Gliclazide and group C was treated
with both the trial drug and Gliclazide. In group C, significant statistical and clinical changes were observed in
reduction of Fasting Blood Sugar followed by group „A‟ and „B‟. Effect on Post Prandial Blood Sugar was highly
significant in group „A‟ followed by group „C‟ and „B‟. There was statistically significant reduction in HbA1c in
group C. Lastly it is concluded that this trial drug is an effective therapeutic medicine for management of
Madhumeha (Type 2 D.M).
Keywords: Haridra, Daruharidra, Amalaki, Madhumeha, Ayurveda, Diabetes.
[Full Text Article]